14365 results for ""Pennsylvania+German"+ACS+study+'Socius'+open+access"

in 11.13 milliseconds.

• UCSF prostate cancer genomics data access committee

  Dac EGAC00001002685

• UCSF SU2C/WCDT Data Access Commitee

  Dac EGAC00001002869

• Data access committee for the HOMOCULTURGEN dataset

  Dac EGAC00001003485

• eHHV-6B-positive Japanese WGS Data Access Committee

  Dac EGAC00001003498

• Circadian Clocks in Diabetes Data Access Committee

  Dac EGAC00001001183

• Hematology Research Unit Helsinki Data Access Committee

  Dac EGAC00001003456

• Hematology Research Unit Helsinki Data Access Committee

  Dac EGAC00001003457

• 2021-inform-RIG-WES data access

  Dac EGAC00001002186

• Epi2Diag methylation datasets Data Access Committee

  Dac EGAC00001003531

• CRUK Pancreatic neuroendocrine tumours Data Access Committee

  Dac EGAC00001002938

• Mesothelial peritoneal adhesions profile Data Access Commitee

  Dac EGAC00001002389

• Data Access Committee for data from EGAS00001004454

  Dac EGAC00001002077

• Data Access Committee for data from EGAS00001006662

  Dac EGAC00001003009

• Data Access Committee for data from EGAS00001005944

  Dac EGAC00001002583

• Whole genome sequencing of six ethnic groups from Burkina Faso, Cameroon, and Tanzania

  We conducted low-coverage (~10x) sequencing of six ethnic groups from three malaria-endemic countries in sub-Saharan Africa, with the aim of characterising genetic diversity and improving imputation performance for genotyped samples in these populations. This data is part of a pre-publication release and is available under managed access. Please see https://www.malariagen.net/data/terms-use/human-gwas-data for more information on MalariaGEN data access policies. The purpose of the project was to support the discovery and understanding of genetic variants that influence human disease. Specifically defined goals were: a. the discovery of single nucleotide variants at frequencies of 1% or higher in diverse populations, b. even more comprehensive discovery (variants down to frequencies of 0.1 - 0.5%) in functional gene regions, and c. discovery of structural variants, such as copy number variants, other insertions and deletions, and inversions, including sequence-level understanding of breakpoints.

  Study EGAS00001003648

• ICGC Data Access Compliance Office

  Dac EGAC00001003040

• Tampere University Hospital Leukemia Research Data Access Committee

  Dac EGAC00001003278

• Nencki Institute NGS Core Facility Data Access Commitee

  Dac EGAC00001001676

• MD Anderson Lymphoma & Myeloma Data Access Committee

  Dac EGAC00001002990

• Lung Cancer Single-cell Data Access Committee

  Dac EGAC00001001220

• Tampere University Hospital Leukemia Research Data Access Committee

  Dac EGAC00001003137

• Data Access Commitee for skin scRNA-seq

  Dac EGAC00001003129

• Department of Gastroenterology and Hepatology Data Access Committee

  Dac EGAC00001003361

• DATA ACCESS COMMITTEE BCTL-IRIBHM

  Dac EGAC00001000120

• Breast Cancer Cell Line Data Access Committee

  Dac EGAC00001000134